Add-on Pilot Trial of Minocycline to Treat Fragile X Syndrome

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

November 30, 2008

Study Completion Date

January 31, 2009

Conditions
Fragile X Syndrome
Interventions
DRUG

Minocycline

50-100 mg PO BID for 8 weeks with an option for a 1 year extension.

Trial Locations (1)

M5S 2C2

Surrey Place Centre, Toronto

Sponsors
All Listed Sponsors
collaborator

Fragile X Research Foundation of Canada

OTHER

lead

FRAXA Research Foundation

OTHER